Advances in the treatment of high-risk and recurrent or refractory neuroblastoma with disialoganglioside monoclonal antibody
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 7 | 7 |
| PDF downloads | 0 | 0 | 2 | 2 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|